Illinois General Assembly - Full Text of SB1805
Illinois General Assembly

Previous General Assemblies

Full Text of SB1805  97th General Assembly

SB1805 97TH GENERAL ASSEMBLY

  
  

 


 
97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012
SB1805

 

Introduced 2/9/2011, by Sen. Pamela J. Althoff

 

SYNOPSIS AS INTRODUCED:
 
20 ILCS 2310/2310-312

    Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. In the provision concerning Multidrug-Resistant Organisms (MDROs), requires the Department to publish a yearly report regarding certain MDRO infections based on a surveillance system substantially similar to the Center for Disease Control and Prevention's National Healthcare Safety Network surveillance system (instead of the Hospital Discharge Dataset).


LRB097 05294 RPM 45348 b

 

 

A BILL FOR

 

SB1805LRB097 05294 RPM 45348 b

1    AN ACT concerning public health.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Department of Public Health Powers and
5Duties Law of the Civil Administrative Code of Illinois is
6amended by changing Section 2310-312 as follows:
 
7    (20 ILCS 2310/2310-312)
8    Sec. 2310-312. Multidrug-Resistant Organisms. The
9Department shall perform the following functions in relation to
10the prevention and control of Multidrug-Resistant Organisms
11(MDROs), including methicillin-resistant Staphylococcus aureus
12(MRSA), vancomycin-resistant (VRE) and certain gram-negative
13bacilli (GNB), as these terms are referenced by the United
14States Centers for Disease Control and Prevention:
15        (1) Except with regard to hospitals, for which
16    administrative rules shall be adopted in accordance with
17    Section 6.23 of the Hospital Licensing Act and Section 7 of
18    the University of Illinois Hospital Act, the Department
19    shall adopt administrative rules for health care
20    facilities subject to licensure, certification,
21    registration, or other regulation by the Department that
22    may require one or more types of those facilities to (i)
23    perform an annual infection control risk assessment, (ii)

 

 

SB1805- 2 -LRB097 05294 RPM 45348 b

1    develop infection control policies for MDROs that are based
2    on this assessment and incorporate, as appropriate,
3    updated recommendations of the U.S. Centers for Disease
4    Control and Prevention for the prevention and control of
5    MDROs, and (iii) enforce hand hygiene requirements.
6        (2) The Department shall:
7            (A) publicize guidelines for reducing the
8        incidence of MDROs to health care providers, health
9        care facilities, public health departments, prisons,
10        jails, and the general public; and
11            (B) provide periodic reports and updates to public
12        officials, health professionals, and the general
13        public statewide regarding new developments or
14        procedures concerning prevention and management of
15        infections due to MDROs.
16        (3) The Department shall publish a yearly report
17    regarding MRSA and Clostridium difficile infections based
18    on a surveillance system substantially similar to the
19    Center for Disease Control and Prevention's National
20    Healthcare Safety Network surveillance system the Hospital
21    Discharge Dataset. The Department is authorized to require
22    hospitals, based on guidelines developed by the National
23    Center for Health Statistics, after October 1, 2007, to
24    submit data to the Department that is coded as "present on
25    admission" and "occurred during the stay".
26        (4) Reporting to the Department under the Hospital

 

 

SB1805- 3 -LRB097 05294 RPM 45348 b

1    Report Card Act shall include organisms, including but not
2    limited to MRSA, that are responsible for central venous
3    catheter-associated bloodstream infections and
4    ventilator-associated pneumonia in designated hospital
5    units.
6        (5) The Department shall implement surveillance for
7    designated cases of community associated MRSA infections
8    for a period of at least 3 years, beginning on or before
9    January 1, 2008.
10(Source: P.A. 95-282, eff. 8-20-07.)